2023.01.26 – Assessment and Management of Neuropsychiatric Disturbances after Traumatic Brain Injury (Recorded Webinar)

A David Strauss Memorial Clinical Lecture recorded webinar featuring Durga Roy, M.D.

To download the webinar, choose the “Download Now” option from the dropdown below. After completing the checkout process, you will receive an email with further instructions and a file that includes information about receiving your ACBIS CEU.

Aired live on January 26, 2023. Includes 1 ACBIS CEU. 

Note: A certificate of attendance/ACBIS CEU certificate will not be available with the purchase of this webinar after January 31, 2026.

In this David Strauss Clinical webinar, Durga Roy, M.D., FACLP, will discuss her clinical experience and research in the assessment and management of neuropsychiatric disturbances after traumatic brain injury.

Learning Objectives:

  1. Identify rates of neuropsychiatric symptoms in the first year of TBI.
  2. Describe clinical and demographic risk factors associated with the development of neuropsychiatric symptoms within the first year of TBI.
  3. List the pharmacologic and psychosocial interventions used to treat neuropsychiatric symptoms after TBI. 

Speaker Bio:

Durga Roy, M.D., FACLP, is an Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine and the Medical Director of the Johns Hopkins Neuropsychiatry and Brain Injury Clinic, and Head Injury Outpatient Psychiatric Day Program. She is the Director of Education for the Johns Hopkins Psychiatry Internship and the Director for the Consult-Liaison Psychiatry Fellowship at Johns Hopkins University School of Medicine. She is board certified in general adult psychiatry, consult-liaison psychiatry, and behavioral neurology/neuropsychiatry. She has authored numerous peer-reviewed publications focused on neuropsychiatric outcomes after traumatic brain injury. Her area of research interest focuses on the neurobiology of depression after traumatic brain injury and the study of prognostic markers for depressive symptoms after traumatic brain injury using resting-state functional neuroimaging techniques.